Market Overview

UPDATE: JP Morgan Upgrades Thermo Fisher Scientific to Overweight on Favorable Risk/Reward

Share:
Related TMO
Buy Thermo Fisher On Amazon Fear-Inspired Dip
Earnings Scheduled For October 25, 2017
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2017 Update (Seeking Alpha)

JP Morgan upgraded Thermo Fisher Scientific (NYSE: TMO) from Neutral to Overweight and raised the price target from $70.00 to $80.00.

JP Morgan noted, "We are upgrading Thermo Fisher Scientific (TMO) from Neutral to Overweight on favorable risk/reward due to conservative guidance that should be at worst achievable, and more likely beatable, and an improving record of capital deployment since management has increasingly focused on the higher bar of ROIC, rather than simply adjusted EPS accretion. The company's robust and growing free cash flow provides clear optionality around additional capital deployment, including but not limited to recent press reports (Reuters) that it is now evaluating a purchase of Life Technologies (LIFE)."

Thermo Fisher Scientific closed at $72.14 on Thursday.

Latest Ratings for TMO

DateFirmActionFromTo
Oct 2017Deutsche BankMaintainsBuy
Oct 2017Leerink SwannMaintainsOutperform
Sep 2017BarclaysMaintainsOverweight

View More Analyst Ratings for TMO
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Analyst Ratings

 

Related Articles (TMO)

View Comments and Join the Discussion!

Partner Center